BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36506283)

  • 1. Predicting survival of patients with spinal metastatic disease using PathFx 3.0 - A validation study of 668 patients in Sweden.
    Carrwik C; Tsagkozis P; Wedin R; Robinson Y
    Brain Spine; 2022; 2():101669. PubMed ID: 36506283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.
    Anderson AB; Wedin R; Fabbri N; Boland P; Healey J; Forsberg JA
    Clin Orthop Relat Res; 2020 Apr; 478(4):808-818. PubMed ID: 32195761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?
    Ogura K; Gokita T; Shinoda Y; Kawano H; Takagi T; Ae K; Kawai A; Wedin R; Forsberg JA
    Clin Orthop Relat Res; 2017 Sep; 475(9):2263-2270. PubMed ID: 28560532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of survival after surgical management of femoral metastatic bone disease - A comparison of prognostic models.
    Meares C; Badran A; Dewar D
    J Bone Oncol; 2019 Apr; 15():100225. PubMed ID: 30847272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the PATHFx decision-support tool on Turkish patients with skeletal metastasis.
    Ozkan K; Ozturan B; Karadag Z; Erol B; Alpan B; Ozger H; Gurkan V; Sofulu O; Yalcinkaya M; Okay E; Forsberg JA
    Indian J Cancer; 2023 Feb; ():. PubMed ID: 36861722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of PATHFx 2.0: An open-source tool for estimating survival in patients undergoing pathologic fracture fixation.
    Overmann AL; Clark DM; Tsagkozis P; Wedin R; Forsberg JA
    J Orthop Res; 2020 Oct; 38(10):2149-2156. PubMed ID: 32492213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?
    Forsberg JA; Wedin R; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2017 Apr; 475(4):1252-1261. PubMed ID: 27909972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can a Bayesian belief network for survival prediction in patients with extremity metastases (PATHFx) be externally validated in an Asian cohort of 356 surgically treated patients?
    Hsieh HC; Lai YH; Lee CC; Yen HK; Tseng TE; Yang JJ; Ling SY; Hu MH; Hou CH; Yang RS; Wedin R; Forsberg JA; Lin WH
    Acta Orthop; 2022 Sep; 93():721-731. PubMed ID: 36083697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
    Sørensen MS; Gerds TA; Hindsø K; Petersen MM
    Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning algorithms to estimate 10-Year survival in patients with bone metastases due to prostate cancer: toward a disease-specific survival estimation tool.
    Anderson AB; Grazal C; Wedin R; Kuo C; Chen Y; Christensen BR; Cullen J; Forsberg JA
    BMC Cancer; 2022 Apr; 22(1):476. PubMed ID: 35490227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations.
    Piccioli A; Spinelli MS; Forsberg JA; Wedin R; Healey JH; Ippolito V; Daolio PA; Ruggieri P; Maccauro G; Gasbarrini A; Biagini R; Piana R; Fazioli F; Luzzati A; Di Martino A; Nicolosi F; Camnasio F; Rosa MA; Campanacci DA; Denaro V; Capanna R
    BMC Cancer; 2015 May; 15():424. PubMed ID: 25998535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
    Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
    Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between different prognostic models to be used for metastatic bone disease on appendicular skeleton in a Chilean population.
    Alfaro PA; Delgado J; Dumas A; Mesa C; Wevar O; Herrera C; Padilla F; Botello E
    Eur J Orthop Surg Traumatol; 2021 Dec; 31(8):1657-1662. PubMed ID: 34677661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting survival for metastatic spine disease: a comparison of nine scoring systems.
    Ahmed AK; Goodwin CR; Heravi A; Kim R; Abu-Bonsrah N; Sankey E; Kerekes D; De la Garza Ramos R; Schwab J; Sciubba DM
    Spine J; 2018 Oct; 18(10):1804-1814. PubMed ID: 29567516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates?
    Janssen SJ; van der Heijden AS; van Dijke M; Ready JE; Raskin KA; Ferrone ML; Hornicek FJ; Schwab JH
    Clin Orthop Relat Res; 2015 Oct; 473(10):3112-21. PubMed ID: 26155769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.
    Sutcliffe P; Connock M; Shyangdan D; Court R; Kandala NB; Clarke A
    Health Technol Assess; 2013 Sep; 17(42):1-274. PubMed ID: 24070110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three predictive scoring systems for morbidity in oncological spine surgery.
    De la Garza Ramos R; Naidu I; Choi JH; Pennington Z; Goodwin CR; Sciubba DM; Shin JH; Yanamadala V; Murthy S; Gelfand Y; Yassari R
    J Clin Neurosci; 2021 Dec; 94():13-17. PubMed ID: 34863427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of seven prognostic scores in patients with surgically treated epidural metastatic spine disease.
    Westermann L; Olivier AC; Samel C; Eysel P; Herren C; Sircar K; Zarghooni K
    Acta Neurochir (Wien); 2020 Jan; 162(1):109-119. PubMed ID: 31781995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in Patients With Spinal Metastatic Disease Treated Nonoperatively With Radiotherapy: Are the SORG-ML Algorithms Relevant?
    Fenn BP; Karhade AV; Groot OQ; Collins AK; Balboni TA; Oh KS; Ferrone ML; Schwab JH
    Clin Spine Surg; 2024 Feb; ():. PubMed ID: 38321614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.